NCT02405026View on ClinicalTrials.gov

Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients

CompletedOBSERVATIONAL

Enrollment

83

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

AsthmaHIV

Trial Locations (1)

27705

Duke Asthma Allergy and Airway Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT02405026 - Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients | Biotech Hunter | Biotech Hunter